HYPER-CARDIO: Hyperoxia and Pulmonary Complications After Cardiac Surgery

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Completed
CT.gov ID
NCT04278066
Collaborator
(none)
300
1
7
42.9

Study Details

Study Description

Brief Summary

The main objective is to demonstrate that hyperoxia in cardiac surgery increase the occurrence of post-operative pulmonary complications

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    300 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Hyper-Cardia Study : Hyperoxia and Pulmonary Complications After Cardiac Surgery
    Actual Study Start Date :
    Feb 5, 2020
    Actual Primary Completion Date :
    Sep 5, 2020
    Actual Study Completion Date :
    Sep 5, 2020

    Outcome Measures

    Primary Outcome Measures

    1. Retrospective study of the average of per and postoperative PaO2 in cardiac surgery [iles analyzed retrospectily from January 1st, 2015 to December 31, 2019 will be examined]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Adult patient (≥18 years old)

    • Patient operated heart surgery with extra-corporal life support

    • Hospitalization in Cardiology intensive and critical care unit

    • Patient operated in HUS between 01/01/2015 and 31/12/2019

    • Subject consent, after information, to the reuse of its data for the purposes of this study

    Exclusion Criteria:
    • Non-consent patient

    • Hypoxemic patient

    • Emergency surgery

    • Patient with post-operative cardiac assist device

    • Patient with guardianship

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Service d'Anesthésiologie - NHC Strasbourg France 67091

    Sponsors and Collaborators

    • University Hospital, Strasbourg, France

    Investigators

    • Study Director: François FISCHER, MD, University Hospital, Strasbourg, France

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Strasbourg, France
    ClinicalTrials.gov Identifier:
    NCT04278066
    Other Study ID Numbers:
    • 7655
    First Posted:
    Feb 20, 2020
    Last Update Posted:
    Oct 7, 2021
    Last Verified:
    Feb 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Strasbourg, France
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 7, 2021